Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed ...
J&J’s separations of Kenvue and DePuy Synthes test whether Innovative Medicine and MedTech create more value together than ...
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics ...
As specialty drug complexity grows, agentic technology puts the right access, adherence, and affordability resources at the ...
Dr. Joe Geraci of NetraMark explains how AI analysis of clinical trial data can uncover hidden responder subgroups, separate ...
Parexel’s Stacy Hurt explains why AI can speed up clinical research but can’t replace the lived experience of patients.
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
White House withdraws Dr. Heidi Overton’s FDA commissioner nomination amid Senate GOP pushback, Pfizer and Verismo advance in ...
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania ...
Pharmaceutical Executive spoke with Ankit Jain, CEO and founder of Infinitus, about how agentic AI models are being deployed ...
Verismo Therapeutics licenses in vivo CAR T engineering technology from Stanford Medicine, while Pfizer licenses in vivo ...
Agentic AI turns wasted windshield time into productive CRM updates and deploys always-on virtual reps to support providers ...